The association of cysteinyl leukotrienes with plasma exudation allowed the authors to form the hypothesis that rates of leukotriene excretion would be increased in the acute phase of systemic capillary leak syndrome (SCLS) and that leukotriene-modifier therapy would reduce the frequency and severity of life-threatening episodes. The authors report the association of SCLS in 3 cases, 1 with seafood-induced anaphylaxis. Rates of urinary leukotriene excretion were greater during the evolution of an episode than after resolution. In a third case, the rate of urinary leukotriene excretion was significantly higher when symptoms were evolving than when they were absent (230 ± 17 vs 110 ± 6 pg/mg, P < 0.001). Treatment with a leukotriene receptor (cys-LT1) antagonist eliminated episodes in 1 patient. Treatment with the 5-lipoxygenase inhibitor zileuton was completely effective in another patient and prevented life-threatening episodes in the patient with SCLS after seafood exposure. The authors' finding that allergen exposure—associated episodes of SCLS were eliminated by allergen avoidance implies that anaphylaxis can present as SCLS. The acute phase of all 3 forms of SCLS (paraprotein associated, anaphylaxis associated, and idiopathic) is associated with increased excretion of cystinyl leukotrienes, and leukotriene-modifier treatment appears to control the disease.
Atkinson JP, Waldmann TA, Stein SF, et al. Systemic capillary leak syndrome and monoclonal IgG gammopathy: studies in a sixth patient and a review of the literature. Medicine (Baltimore)1977;56:225-239.
2.
Cain JR, Bourgoignie JJ, Ahn SY, et al. Systemic capillary leak syndrome (SCLS): a rare cause of systemic edema. Kidney Int1986;29:181.
3.
Droder RM, Kyle RA, Greipp PRControl of systemic capillary leak syndrome with aminophylline and terbutaline . Am J Med1992;92:523-526.
4.
Amoura Z., Papo T., Ninet J., et al. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med1997;103:514-519.
5.
Clarkson B., Thompson D., Horwith M., et al. Cyclical edema and shock due to increased capillary permeability . Am J Med1960;29:193-216.
6.
Lofdahl CG, Solvell L., Laurell AB, et al. Systemic capillary leak syndrome with monoclonal IgG and complement alterations: a case report on an episodic syndrome. Acta Med Scand1979;206:405-412.
7.
Fellows IW, Powell RJ, Toghill PJ, et al. Epoprostenol in systemic capillary leak syndrome. Lancet1988;2:1143.
Marasini B., Bergamaschini L., Boccassini G., et al. Systemic capillary leak syndrome: evaluation of single protein fractions in serum and in interstitial fluid. Bibl Anat1979;18:41-43.
10.
Zhang W., Ewan PW, Lachmann PJThe paraproteins in systemic capillary leak syndrome. Clin Exp Immunol1993;93:424-429.
11.
Lassoued K. , Clauvel JP, Similowski T., et al. Pulmonary infections associated with systemic capillary leak syndrome attacks in a patient with hypogammaglobulinemia . Intensive Care Med1998;24:981-983.
12.
Rondeau E., Sraer J., Bens M., et al. Production of 5-lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease). Eur J Clin Invest1987;17(1):53-57.
13.
Cahill RA, Zhao Y., Murphy R., et al. High urinary leukotriene E4 (LTE4) and thromboxane 2 (TXB2) levels are associated with capillary leak syndrome in bone marrow transplant patients. Adv Prostaglandin Thromboxane Leukotriene Res1991;21B:525-528.
14.
Harel Z., Lilly C., Riggs S., et al. Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: a pilot study. J Adolesc Health2000;27:151-154.
15.
Asano K., Lilly CM, O'donnell WJ, et al. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J Allergy Clin Immunol1995;96(5 pt 1):643-651.
16.
Arm JP, Thien FC, Lee THLeukotrienes, fish-oil, and asthma. Allergy Proc1994;15:129-134.
17.
Tahirkheli NK , Greipp PRTreatment of the systemic capillary leak syndrome with terbutaline and theophylline. Ann Int Med1999;130:905-909.
18.
Garcia-Bragado F., Lima J., Monteagudo M., et al. Generalized capillary hyperpermeability syndrome: a rare cause of hypovolemic shock and cyclic generalized edemas: contribution of 2 cases. Med Clin (Barc)1987;89:426-428.
19.
Janin-Manificat L., Martelet M., Guy H., et al. Hypovolemic shock caused by increased capillary permeability: a case without monoclonal dysglobulinemia. Nouv Presse Med1982;11:2716.
20.
de Barros RT, Chocair PR, Ianhez LE, et al. Systemic capillary leak syndrome: report of a case and review of the literature. Rev Hosp Clin Faculty Med Sao Paulo1983;38:170-172.
21.
Horwith M., Hagstrom JW, Riggins RC, et al. Hypovolemic shock and edema due to increased capillary permeability . JAMA1967;200:101-104.
22.
George C., Regnier B., Le Gall JR, et al. Hypovolaemic shock with oedema due to increased capillary permeability . Intensive Care Med1978;4:159-163.
23.
Doorenbos CJ , van Es A., Valentijn RM, et al. Systemic capillary leak syndrome: preventive treatment with terbutaline. Neth J Med1988;32(3-4):178-184.
24.
Maestracci P., Benoit P., Dupeyrat J., et al. Hypovolaemic shock due to increased capillary permeability. Nouv Presse Med1981 ;10:329-330.
25.
Ewan PW, Lachmann PJ, Morice AH, et al. Treatment of systemic capillary leak syndrome. Lancet1988;2:1496.
26.
Lagrue G., Behar A., Kazandjian M., et al. Idiopathic cyclic edema: the role of capillary hyperpermeability and its correction by ginkgo biloba extract. Presse Med1986;15:1550-1553.
